多发性硬化症的长期转移因子治疗
Long-term transfer-factor treatment for multiple sclerosis.
作者信息
Fog T, Pedersen L, Raun N E, Kam-Hansen S, Mellerup E, Platz P, Ryder L P, Jakobsen B K, Grob P
出版信息
Lancet. 1978 Apr 22;1(8069):851-3. doi: 10.1016/s0140-6736(78)90194-0.
PMID:76798
Abstract
In groups of 16 patients with multiple sclerosis, 13 months' double-blind treatment with transfer factor from random normal donors differed from placebo treatment only in producing a temporary restoration of lymphocyte reactivity to measles virus antigen, and did not arrest the degeneration of nerve tissue.
摘要
在每组16例多发性硬化症患者中，接受来自随机正常供体的转移因子进行13个月的双盲治疗，与安慰剂治疗的区别仅在于能使淋巴细胞对麻疹病毒抗原的反应性暂时恢复，且未能阻止神经组织的退化。
Zotero 插件